Overview
Non-dose-related drug-induced neutropenia refers to a decrease in neutrophil count not directly proportional to the administered drug dose, often complicating treatment due to increased infection risk 1.Diagnosis
Clinical Presentation: Unexplained neutropenia without dose escalation 1.
Laboratory Tests: Complete blood count (CBC) with differential to confirm neutropenia 1.
Drug History: Detailed medication review to identify potential causative agents 1.
Causality Assessment: Use of causality assessment tools like WHO-UMC system for evaluating drug causality 1.Management
Discontinue Suspect Drug: If a causative drug is identified, discontinue it promptly 1.
Supportive Care: Administer granulocyte colony-stimulating factor (G-CSF) for severe neutropenia 1.
Monitor Closely: Frequent CBC monitoring to assess recovery of neutrophil count 1.
Infection Prevention: Vigilant infection surveillance and prompt treatment of any signs of infection 1.Special Populations
No Specific Guidance: Abstracts do not provide specific recommendations for pregnancy, pediatrics, elderly, or comorbidities 12.Key Recommendations
Implement thorough medication review to identify potential drugs causing neutropenia (Evidence: Expert opinion) 1.
Discontinue the suspected drug immediately upon identifying a causal relationship (Evidence: Expert opinion) 1.
Initiate supportive measures including G-CSF for severe cases (Evidence: Expert opinion) 1.References
1 Jones J, Swart A, Tommy E, Cohen K, Stewart A, Voget J et al.. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2020. link
2 Garba M, Odunola MT, Ahmed BH. Effect of study protocol on the interactions between cimetidine and paracetamol in man. European journal of drug metabolism and pharmacokinetics 1999. link